Transcatheter aortic valve replacement (TAVR)
What is transcatheter aortic valve replacement?
Transcatheter aortic valve replacement (TAVR)—also known as transcatheter aortic valve implantation (TAVI)—is a minimally invasive cardiac surgical procedure performed on high-risk patients suffering from severe aortic stenosis, or a narrowing of the aortic valve. Approximately 250,000 Americans currently suffer from this condition, which can have debilitating symptoms that affect normal day-to-day activities.
TAVR has shown to significantly improve survival rates and quality of life, serving as a successful alternative to traditional cardiac surgery. It's part of the future of cardiac surgery, which is why our team is involved with the next generation of TAVR through clinical trials for both low risk and mitral valve replacement.
Traditionally, open-heart surgery has been the most common treatment for severe aortic stenosis. However, patients with severe aortic stenosis are often elderly and have other complicated medical conditions that make invasive surgery too risky. These patients once had little or no treatment options, but are now being considered for minimally invasive valve replacement at Northwell Health.
Northwell was one of the first health systems in the region to offer the TAVR heart valve procedure. Similar to a technique used to implant cardiac stents into clogged arteries, TAVR involves a physician guiding a catheter through an artery to the heart with an artificial valve attached. The valve is anchored inside the aorta and expands, helping to restore blood flow.
Our experts discuss how we look at aortic stenosis.
We pioneered robotic surgery, and today we're one of the most experienced teams in New York. Learn how smaller incisions, better visualization and an integrated cross-functional team minimizes your recovery time and maximizes your outcome.
Listen to our experts talk about what sets us apart as leaders in cardiac surgery.